Ads
related to: sanofi pharmaceuticals- Careers
Join our Mission to Improve
the Lives of Patients.
- About Us
Discover the Unique Approach
That Makes Genmab Different.
- Pipeline
Review our Pipeline and
See How We're Changing Treatment.
- Sign Up
Sign Up for Updates, News
and Much More.
- Antibody Science
Explore Our Unique Platforms
For Creating Antibody Treatments.
- Approved Medicines
See the Approved Treatments
Using Our Antibody Science.
- Careers
Search results
Novavax Stock Just Tripled. Is It Too Late to Buy? | The Motley Fool
The Motley Fool· 2 days agoThe biotech soared 190% in two trading sessions after announcing a $1.2 billion vaccine-licensing...
Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
Pharmaceutical Technology via Yahoo Finance· 4 days agoCytokines such as these play key roles in inflammation. Regeneron and Sanofi, who began working...
COVID was a final blow to some NJ suburban office parks. Here's how they're morphing
The Bergen Record via Yahoo News· 1 day agoON3, Clifton/Nutley In 2013, the pharmaceutical company Hoffmann-La Roche walked away from the...
Why Novavax Stock More Than Doubled Today
Motley Fool via Yahoo Finance· 7 days agoIt's not the report, however, driving the bulk of today's oversize gain -- it's the announcement made in conjunction with it. The company is partnering...
France bags $16 billion investment boost from Microsoft, Pfizer and others as Macron goes on FDI...
Fortune via Yahoo Finance· 4 days agoOfficials announced today that the country has bagged €15 billion ($16.2 billion) in investments...
Why Novavax Stock More Than Doubled Today | The Motley Fool
The Motley Fool· 7 days agoShares of Novavax (NVAX 98.66%) are up 12% as of midday Friday following the release of the...
If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now | The Motley Fool
The Motley Fool· 1 day agoIf you'd invested $10,000 in Novavax (NVAX 9.26%) a year ago, you would have made a risky bet. Prior...
3 Cheap Biotech Stocks to Buy Now: May 2024
InvestorPlace· 3 days agoThe biotech industry is notably risky, but can produce stocks that see massive gains within a day. Well, many of these companies depend on FDA approval...
1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell?
Motley Fool via Yahoo Finance· 2 days agoUnderstandably, Novavax's share price leaped on news of the potentially lucrative deal with the...
1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell? | The Motley Fool
The Motley Fool· 2 days agoNovavax (NVAX -4.30%) took a turn in the investor spotlight in early May, when the vaccine...
